Cost of Achieving Combined Improvements in HbA1c and Weight without Hypoglycaemia over 4 Years in a Post-Hoc Analysis of Dapagliflozin + MET Vs Glipizide + MET von Johansen, P, Mukherjee, J, Sörstadius, E, Sternhufvud, C

Volltext

PDB43 - Cost of Achieving Combined Improvements in HbA1c and Weight without Hypoglycaemia over 4 Years in a Post-Hoc Analysis of Dapagliflozin + MET Vs Glipizide + MET von Johansen, P, Mukherjee, J, Sörstadius, E, Sternhufvud, C

Volltext

SAT-142 THE ECONOMIC AND PATIENT BURDEN OF CHRONIC KIDNEY DISEASE (CKD): RESULTS FROM AN INTERNATIONAL CKD POLICY EVALUATION von Darlington, O., GARCIA SANCHEZ, J.J., Sörstadius, E., Parker, B., McEwan, P.

Volltext

PDB58 - A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus von Henriksson, M, Jindal, R, Sternhufvud, C, Sörstadius, E, Bergenheim, K, Willis, M

Volltext

A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus von Henriksson, M, Jindal, R, Sternhufvud, C, Sörstadius, E, Bergenheim, K, Willis, M

Volltext

SAT-141 THE GLOBAL EPIDEMIOLOGICAL BURDEN OF CHRONIC KIDNEY DISEASE ACCORDING TO THE KDIGO CATEGORIES DEFINED BY eGFR AND UACR: A SYSTEMATIC LITERATURE REVIEW von Murton, M., Goff-Leggett, D., Bobrowska, A., James, G., GARCIA SANCHEZ, J.J., Wittbrodt, E., Nolan, S., Sörstadius, E., Pecoits-Filho, R., Tuttle, K.

Volltext

PGI19 PRESCRIPTION RATES AND ADHERENCE TO PROTON PUMP INHIBITOR THERAPY AMONG PATIENTS WHO REQUIRE LOW-DOSE ACETYLSALICYLIC ACID FOR CARDIOVASCULAR PREVENTION von Sörstadius, E, Herlitz, J, Nauclér, E, Naesdal, J

Volltext

POSA138 When Gliflozins Save Health Insurance Money: The French Case von Chevalier, J, Boussahoua, M, Rachdi, L, Garcia Sanchez, JJ, Ghedira, M, Rao, N, Sorstadius, E, Poulnais, R

Volltext

PCV147 EXPERIENCE WITH UPPER GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH CARDIOVASCULAR RISK TREATED WITH LOW-DOSE ACETYLSALICYLIC ACID von Sörstadius, E, Thompson, VJ, Pratt, SE, Delgado, JP, Nauclér, E, Næsdal, J, Junghard, O

Volltext

PCV131 NONADHERENCE AND DISCONTINUATION OF LOW-DOSE ACETYLSALICYLIC ACID IN PATIENTS WITH CARDIOVASCULAR RISK: THE IMPACT OF GASTROINTESTINAL SYMPTOMS von Sörstadius, E, Thompson, VJ, Pratt, SE, Delgado, JP, Elkin, E, Nauclér, E, Næsdal, J, Junghard, O

Volltext

PCV141 UPPER GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH CARDIOVASCULAR RISK TAKING LOW-DOSE ACETYLSALICYLIC ACID: AN OBSERVATIONAL STUDY von Sörstadius, E, Thompson, VJ, Pratt, SE, Delgado, JP, Elkin, E, Nauclér, E, Næsdal, J, Junghard, O

Volltext

SAT-143 HEALTH RELATED QUALITY OF LIFE WEIGHTS FOR ECONOMIC EVALUATION THROUGH DIFFERENT STAGES OF CHRONIC KIDNEY DISEASE: A SYSTEMATIC LITERATURE REVIEW von Cooper, J., GARCIA SANCHEZ, J.J., Sorstadius, E., Briggs, A., McFarlane, P.A., Lloyd, A.

Volltext